You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

EGFR L718X

Showing 1 - 25 of 2,952
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC, EGFR G719X, EGFR L861Q Trial in Chongqing (Furmonertinib 160 mg, Q.D.)

Recruiting
  • Non-small Cell Lung Cancer
  • +3 more
  • Furmonertinib 160 mg, Q.D.
  • Chongqing, Chongqing, China
  • +2 more
Sep 16, 2022

PFS Trial in Qingdao (afatinib)

Recruiting
  • PFS
  • Qingdao, Shandong, China
  • +1 more
Feb 23, 2022

Lung Tumor, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-701, osimertinib, carboplatin)

Recruiting
  • Lung Neoplasm
  • +26 more
  • Boston, Massachusetts
  • +6 more
Jun 23, 2022

NSCLC Trial in Worldwide (Osimertinib, Savolitinib, Gefitinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • Duarte, California
  • +52 more
Jan 19, 2023

NSCLC Trial (Furmonertinib)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • (no location specified)
Aug 10, 2023

Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer Trial in Detroit (biological,

Completed
  • Metastatic Pancreatic Adenocarcinoma
  • +3 more
  • Aldesleukin
  • +9 more
  • Detroit, Michigan
    Wayne State University/Karmanos Cancer Institute
Mar 30, 2022

Carcinoma, Non-Small-Cell Lung Trial in Worldwide (Savolitinib, Osimertinib, Pemetrexed)

Not yet recruiting
  • Carcinoma
  • Non-Small-Cell Lung
  • Orange City, Florida
  • +78 more
Jul 20, 2022

NSCLC Trial in Singapore (Afatinib 40 MG)

Not yet recruiting
  • NSCLC
  • Afatinib 40 MG
  • Singapore, Singapore
    National University Hospital
Sep 25, 2023

Lung Cancer Trial in Worldwide (T790M+ Testing, Baseline Visit Blood & Urine Testing, Baseline ECG)

Completed
Has Results
  • Lung Cancer
  • T790M+ Testing
  • +4 more
  • Buenos Aires, Argentina
  • +200 more
Nov 10, 2021

Lung Cancer, TKI Resistance, EGFR Sensitive Mutation Trial (Anlotinib, Penpulimab)

Not yet recruiting
  • Lung Cancer
  • +4 more
  • (no location specified)
Sep 15, 2023

Non Small Cell Lung Cancer Trial in Seoul (Neoadjuvant lazertinib)

Recruiting
  • Non Small Cell Lung Cancer
  • Neoadjuvant lazertinib
  • Seoul, Korea, Republic of
    Konkuk University Medical Center
Jul 20, 2022

Prevention & Control Trial in Worldwide (Rivaroxaban (Xarelto, BAY59-7939), Aspirin, Aspirin )

Completed
Has Results
  • Prevention & Control
  • Rivaroxaban (Xarelto, BAY59-7939)
  • +5 more
  • Birmingham, Alabama
  • +564 more
Nov 3, 2022

A Retrospective Pharmacogenomics Research of EGFR-TKIs,Gefitinib

Recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • +4 more
    • Guangzhou, Guangdong, China
      Cancer Center, Sun Yat-sen University
    Oct 25, 2022

    Non-squamous NSCLC Trial (biological, drug, dietary supplement)

    Not yet recruiting
    • Non-squamous NSCLC
    • Pembrolizumab
    • +7 more
    • (no location specified)
    Feb 20, 2023

    EGF-R Positive NSCLC, Non Small Cell Lung Cancer, EGFR Exon 19 Deletion Trial in Bogotá (Stereotactic Body Radiation Therapy

    Not yet recruiting
    • EGF-R Positive Non-Small Cell Lung Cancer
    • +4 more
    • Stereotactic Body Radiation Therapy SBRT
    • Bogotá, Colombia
      CTIC - Centro de Tratamiento e Investigación Sobre Cáncer Luis C
    Aug 16, 2023

    NSCLC Trial in Guangzhou (Neratinib tablets)

    Not yet recruiting
    • NSCLC
    • Neratinib tablets
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Sep 1, 2023

    Treatment, Treatment Side Effects Trial in China (YK-029A)

    Recruiting
    • Treatment
    • Treatment Side Effects
    • Hefei, Anhui, China
    • +34 more
    Mar 15, 2023

    NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in Worldwide (Furmonertinib)

    Recruiting
    • Non-Small Cell Lung Cancer
    • +14 more
    • Glendale, California
    • +12 more
    Feb 2, 2023

    NSCLC With Mutation in Epidermal Growth Factor Receptor Trial in Kunming (Combined therapy of anlotinib and aumolertinib)

    Recruiting
    • Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
    • Combined therapy of anlotinib and aumolertinib
    • Kunming, Yunnan, China
      First Affiliated Hospital of Kunming University
    Oct 22, 2023

    Heart Failure, Chronic Kidney Disease Trial in Worldwide (AZD9977, Dapagliflozin)

    Recruiting
    • Heart Failure
    • Chronic Kidney Disease
    • Hot Springs National Park, Arkansas
    • +279 more
    Feb 1, 2023

    NSCLC Trial in Worldwide (Lazertinib, Amivantamab, Carboplatin)

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Los Angeles, California
    • +83 more
    Jan 31, 2023

    Chronic Kidney Disease Trial in Worldwide (Zibotentan, Dapagliflozin, Placebo)

    Recruiting
    • Chronic Kidney Disease
    • Huntsville, Alabama
    • +251 more
    Dec 22, 2022

    Lung Cancer Trial in Worldwide (Erlotinib, Bevacizumab)

    Completed
    Has Results
    • Lung Cancer
    • Caen, France
    • +47 more
    Aug 23, 2022

    NSCLC Trial in Japan, Korea, Republic of, Singapore (capmatinib, pemetrexed, cisplatin)

    Terminated
    • Carcinoma, Non-Small-Cell Lung
    • Kashiwa, Chiba, Japan
    • +3 more
    Jan 31, 2023

    Advanced Lung Adenocarcinoma Trial (TCM Formula, Placebo)

    Completed
    • Advanced Lung Adenocarcinoma
    • TCM Formula
    • Placebo
    • (no location specified)
    Jan 9, 2022